HOME >> MEDICINE >> NEWS
New allergy vaccine provides long-lasting hay fever relief after just 6 weeks of shots

Researchers at The Johns Hopkins University School of Medicine have successfully used an experimental DNA-based vaccine to protect against ragweed allergies, commonly known as hay fever, after just six injections. Patients receiving the vaccine showed an average 60 percent reduction in allergy symptoms compared to those receiving a placebo.

The experimental therapy holds the promise of one day eliminating the need for traditional allergy medicines targeting allergy symptoms, such as nasal steroids and antihistamines, and providing a safer, faster replacement for immunotherapy regimens, which are costly and take years to work, the researchers say.

The Hopkins study, conducted during two fall ragweed ("hay fever" ) seasons in Baltimore, Md., enrolled 25 volunteers, ages 23 to 60, with a demonstrated history of ragweed allergy. Fourteen people received the vaccine, administered as six weekly shots, while 11 others received placebo injections.

During the test period, allergic symptoms were monitored and recorded, right down to how often volunteers' noses ran and how many times they sneezed. Compared to the placebo group, those who received the vaccine exhibited a 60 percent reduction in all of their allergy symptoms, including sneezing, runny nose, watery eyes and itching.

Relief from allergic symptoms was as pronounced in the second year as in the first, even though no more vaccine was administered. Lead investigator Peter Creticos, M.D., medical director of the Johns Hopkins Asthma and Allergy Center in Baltimore, explained that such prolonged relief is an important part of his team's findings because it appears that the vaccine's efficacy doesn't wear off quickly. A new study, currently under way, will further examine the drug's lasting effects in a larger group of participants.

Creticos' current findings are published in the Oct. 5 issue of the New England Journal of Medicine.

"This therapeutic interv
'"/>

Contact: Jeff Ventura
jventur4@jhmi.edu
410-955-7832
Johns Hopkins Medical Institutions
4-Oct-2006


Page: 1 2 3

Related medicine news :

1. Vacuum cleaning ineffective in allergy avoidance
2. World-leading innovation in child-allergy detection
3. Study shows six-injection allergy vaccine tames hay fever for at least 2 years
4. Experimental ragweed therapy offers allergy sufferers longer relief with fewer shots
5. Prebiotics can cut development of skin allergy in babies at high risk
6. Researchers demonstrate potential mechanism of food allergy
7. Desensitization protocol overcomes allergy to clopidogrel
8. Evidence of estrogen and progesterone hormone allergy has been discovered by Texas researchers
9. New labelling on foods still not clear enough for allergy sufferers
10. Some outgrow allergy to tree nuts, Johns Hopkins Childrens Center experts report
11. New food allergy research consortium focuses on peanut allergy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... ... feature 150+ Hospital and Health System Executive Speakers including: , , ... of the United States of America: George W. Bush , Boxing Legend, Successful ... Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
(Date:3/23/2017)... ... 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... VoiceAmerica, recently talked on her program about how she is looking forward to World ... of an important distinction. World Water Day, Kleyne pointed out, is an occasion for ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... improve all aspects of people’s health and nutrition, announced its product Leyzene is ... , Natural Subsistence develops nutritional supplements that help people improve all aspects of ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, NC introduce ... a solid foundation. As experts in dangerous situations the Inflow IQ team can ... Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and ... of ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It ... to the association, but also to the Health Care Quality and Patient Safety movements. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... company focused on the development of a once-daily, ... or NASH, and other liver diseases, today reported ... ended December 31, 2016, and announced new and exciting ... potential direct effect on liver fibrosis. The data ...
(Date:3/23/2017)... , March 23, 2017 ReNeuron reported ... CTX cells in chronic stroke patients, despite not meeting the ... outcome measure, the Action Research Arm Test (ARAT). As a ... a pivotal controlled clinical study in 2017. Beyond CTX, we ... trial in 2017 and Phase I data from its critical ...
(Date:3/22/2017)... 2017 ReportsnReports.com adds Global Vagus ... report. The global vagus nerve stimulation market analyst says ... toward minimally invasive VNS procedures. Few years ago, VNS ... countries having high standards of healthcare infrastructure. ... Browse ...
Breaking Medicine Technology:
Cached News: